| 摘要 |
Administered anti-craving compositions are disclosed for preventing and treating patients with addictions comprising an effective amount of at least one alpha-pyrone compound formulated into a physiologically acceptable carrier medium. Additionally, novel compositions are disclosed as substitutes for alcoholic beverages comprising an effective amount of at least one alpha-pyrone compound formulated into alcoholic and non-alcoholic beer, wine and distilled spirits beverages.
|
